Anesu oversees investor management, product vision, and corporate development for MetaDigital. He has 8 years’ experience working in venture capital and financial services for the Export Development Canada (EDC) , MCAN Mortgage Corporation and Outlier Ventures respectively. Anesu has helped advise and develop architecture for the crypto economics and successful 2 nd ever Initial Exchange Offering (IEO)on Binance for Fetch AI raising $15MM. He holds a bachelor’s degree in Actuarial Mathematics from the University of Manitoba (2012). He also holds an MBA and Graduate Diploma in Financial Engineering from Schulich School of Business. Anesu has won the Enterprise Blockchain Award for best research paper Token Economics Creation in 2019

Susan has over 40 years’ experience in the health care consulting, pharmacy benefit management industry. In her many years in the pharmacy benefits and health care anti-fraud industry, Susan has developed a broad understanding of criminological theory application to fraud and investigation techniques and enhancements. Susan specifically specializes in analytics and Big Data combinations to solve issues. Both of her inventions, the COPs^TM and CARs^TM systems are patented products through the United States Patent Office.

Susan has a Bachelor of Science Degree in criminal justice from Northeastern Illinois University, a master’s degree in criminal justice from Boston University, Metropolitan College and a doctoral degree from the University of Portsmouth, United Kingdom. She is a Certified Registered Pharmacy Technician in the State of Illinois (license # 049-123224) and a Licensed Private Detective in the State of Illinois (license # 115.002527). Susan is a member of the Professional Council for Roosevelt University, School of Pharmacy. In 2012, Susan earned her Accredited Healthcare Fraud Investigator (AFHI) designation from the National Healthcare Anti-Fraud Association.

Bill Lucia is the former Chairman, President and Chief Executive Officer of HMS, a leading healthcare analytics and technology company. He served as CEO from 2009 to 2021 and was named Chairman of the Board of Directors in July 2015.

Under Bill’s leadership, HMS grew to $673 million in revenue, serving 500 healthcare payers and 50 government agencies in 40-plus states and 31 of the 38 private health insurers in Australia.

Prior to becoming CEO, Bill served as HMS’ president and chief operating officer, driving operational excellence and delivering sustainable growth.

Dr. Ana Gupte is a well-recognized Strategy, Finance and Innovation leader with over two decades of experience in the field of Healthcare Services and Digital Health. Most recently, Dr. Gupte served as SVP, Chief Strategy and Innovation Officer at Florida Blue and its parent GuideWell. She is widely recognized within healthcare investment, industry and policy circles for her thought leadership over her 12 years of coverage as Senior Equity Analyst at the Wall Street firms of Leerink Partners and Sanford C. Bernstein. Ana has been recognized as a Top 3 Analyst in the Institutional Investor 2011 and 2012 All America Research Team and Runner-Up in the 2010 and 2016. She was the top stock picker within FT Thomson StarMine Healthcare Providers and Services in 2012. Ana brings her extensive experience within healthcare, both in industry and management consulting to bear in her differentiated perspective on innovation and disruption in the healthcare and digital health universe. She served as Managing Director in Corporate Strategic Planning at Aetna, Inc., several years in healthcare strategy consulting at McKinsey & Company and headed up the Worldwide Drug Development Strategy Department at Pfizer, Inc. She is a frequent contributor on all things healthcare on CNBC, Bloomberg TV, and is widely quoted in print media including NY Times, WSJ, Barrons and Forbes. Ana has a B.S. in Chemical Engineering from Bombay University, and an M.S. and Ph.D. in Biomedical Engineering from the Pennsylvania State University. She has graduated from the two-year Executive Management program at the Wharton Business School.

Dr. Robinson currently works as an Entrepreneur in Residence at Blue Cross Blue Shield Nebraska. Her primary responsibilities include identifying, sourcing, and initiating due diligence activities to assess the feasibility of novel business models, investment, regulatory, and commercialization success for digital health, care delivery, rapid medical diagnostics, and predictive analytics products and solutions. Before her work with Blue Cross Blue Shield Nebraska, she was the Co-Founder and Senior Principal, Business Development of Fortis Industries, a full-service healthcare technology management company providing medical equipment sales, repair, and biomedical technician education to the federal government and organizations abroad. Dr. Robinson was also Co-founder and Chief Medical Officer of Syan Biosciences. During her tenure at Syan Biosciences, she was principally responsible for creating Syan’s product and commercialization strategy for its point-of-care diagnostic test for the developing world. In this role, she identified and evaluated in-licensing opportunities and developed specific expertise in point-of-care diagnostic manufacturing, regulatory, pricing, and market intelligence relative to the target markets. Earlier in her career, Dr. Robinson held multiple senior executive roles at MedImmune, Inc. (acquired by Astra Zeneca) and Thermo Electron Corporation, Point of Care, and Rapid Diagnostics Division (Thermo Fisher). She has served as a mentor and advisor to over 20 startup companies. Dr. Robinson earned her MD degree from the University of Kansas School of Medicine, an MBA in Health Administration from the University of Colorado at Denver and a BA in Microbiology from the University of Kansas.

Hal W. Pedersen is one of the world’s leading experts on economic scenario generation. His interest in this area began in the late 1980s with research on interest rate models. Dr. Pedersen was a Managing Director with Conning where he lead the Quantitative Finance team and was one of the principal architects of GEMS, Conning’s award winning economic and capital market scenario generator. He is an Associate of the Society of Actuaries and has more than 20 years academic and industry experience in the application of financial economics to insurance. He was L.A.H. Warren professor of actuarial science at the University of Manitoba from 2003 through 2011 and served on the actuarial faculty at Georgia State University from 1996 through 2001. He is Vice-Chair of the Society of Actuaries Investment Section council.

Beth T. O’Rorke is strategic, results-driven, and energetic leader with over twenty-five years of broad business and technology expertise across healthcare, retail, and financial services insurance. She is an effective advisor to senior management on technology investment levels, industry trends, and emerging technologies. She has led significant improvements in key performance objectives to achieve the corporate strategy. She was recognized as Boston CIO of the Year, ORBIE Awards, 2018 (nominated in top 25 overall / top 5 in healthcare) and as Top 20 CIOs Shaping the Future of Technologies by Warner Communications in 2020. Beth has extensive experience in leading transformation initiatives across various industries with more than 25 years of experience building best-in-class business solutions and operations in the retail, insurance, and consumer industries at companies including SVP and CIO at BCBSMA (2015-2020) and executive positions at Allmerica Financials (currently Hanover Insurance), Staples, Inc., and Ahold Delhaize in the Netherlands. Beth has her MBA from the Bentley University Graduate School of Business and holds a bachelor’s degree in Business Administration from Providence College.

Ian Duncan is Adjunct Professor of Actuarial Statistics at the University of California Santa Barbara and president of Santa Barbara Actuaries Inc. a healthcare analytics firm. Dr. Duncan holds a graduate degree in Economics from Balliol College, Oxford and a PhD in actuarial statistics from Heriot-Watt University, Edinburgh. He is a fellow of a number of actuarial organizations. He has founded or co-founded a number of healthcare analytics companies, including Solucia Inc. (now part of EXL Service). He is active in public policy and healthcare reform and served on the boards of directors of the Commonwealth of Massachusetts Health Insurance Connector Authority from 2007-2014 and the Society of Actuaries, 2012-2015. He serves on the advisory boards of a number of healthcare start-up companies. He is the author of more than 70 peer-reviewed papers, and several books and book chapters. His latest book, a second edition of “Healthcare Risk Adjustment and Predictive Modeling” (Actex Publications) was published in May 2018.